This enduring activity highlights key discussion points from the 2026 ASCO event and aims to improve clinicians’ knowledge and competence in incorporating novel HER2-directed TKIs into treatment plans for patients with advanced HER2-mutated non-small cell lung cancer. As a result of this educational curriculum, learners will be better able to: 1. Specify how TKIs may address unmet therapeutic needs for diverse patient populations with HER2-mutated NSCLC; 2. Interpret the clinical evidence for emerging oral TKIs for patients with previously treated HER2-mutated NSCLC; and, 3. Assess which patients may be candidates for oral HER2-targeting TKIs, as they become available, in the context of the current standard of care. Learners have access to downloadable materials for future use in practice.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 27 Trinity Place, Suite 185
Pricing
99% of listed courses are free
156 of 157 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Internal Medicine
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Infectious Disease
- Interventional Cardiology
- Maternal-Fetal Medicine
- Medical Oncology
- Nephrology
- Neurocritical Care
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Urology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Microlearning
- includes Online course / module
- Credit · Up to 0.5 credits
- Commercial Support
-
ReleasedJun 23, 2026
-
Last day to claim creditJun 23, 2027 9 months left
-
Medscape, LLC Autumn Updates: Exploring Innovations in EGFR-Mutated NSCLC
-
PRIME Education, Inc. (PRIME®) Clinical Momentum: Advancements for Menin Inhibitors in NPM1-Mutated AML
-
Clinical Care Options, LLC (dba Decera Clinical Education) Management of a Patient With EGFR-Mutated NSCLC and Brain Metastases
-
Answers in CME Inc. (AiCME) Beyond the Biomarker: Bridging Patient Voices and Precision Care in HER2-Mutant NSCLC
-
Answers in CME Inc. (AiCME) What s Now and What s Next for ADCs in NSCLC? Integrating HER2- and TROP2-Targeted Therapies Into the Evolving Treatment Landscape
-
Answers in CME Inc. (AiCME) Cracking the Code of KRAS-Mutant NSCLC: Evidence for Emerging Therapies in First-Line Settings
